$BHC News

BHC Q3 Earnings Preview: Here's What You Should Know

Bausch Health Canada Announces Expanded Public Reimbursement for (Pr)OKEDI® (Risperidone for Extended-Release Injectable Suspension) Across Canada for the Treatment of Schizophrenia

Bausch Health Canada Announces Expanded Public Reimbursement For PrOKEDI 75 Mg And 100 Mg, With Coverage Now Available In Seven Provinces And Multiple Federal Drug Plans

Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway

Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway

Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026

Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026

Bausch Health (BHC) Expands Probiotic Skincare Bet To Six New Markets

Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets

Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets

(Pr)SILIQ® (brodalumab injection) Now Reimbursed Under Alberta's Public Drug Plan, Improving Access for Eligible Patients with Moderate to Severe Plaque Psoriasis

Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia

Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners

Can Bausch (BHC) Run Higher on Rising Earnings Estimates?

Bausch (BHC) Upgraded to Buy: Here's What You Should Know

Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month

Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board

Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance

Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook